Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ1 Opioid Receptor Mechanism

+ See all authors and affiliations

Science  27 Jun 1997:
Vol. 276, Issue 5321, pp. 2048-2050
DOI: 10.1126/science.276.5321.2048

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


The effects of the active ingredient of Cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), and of the highly addictive drug heroin on in vivo dopamine transmission in the nucleus accumbens were compared in Sprague-Dawley rats by brain microdialysis. Δ9-THC and heroin increased extracellular dopamine concentrations selectively in the shell of the nucleus accumbens; these effects were mimicked by the synthetic cannabinoid agonist WIN55212-2. SR141716A, an antagonist of central cannabinoid receptors, prevented the effects of Δ9-THC but not those of heroin. Naloxone, a generic opioid antagonist, administered systemically, or naloxonazine, an antagonist of μ1 opioid receptors, infused into the ventral tegmentum, prevented the action of cannabinoids and heroin on dopamine transmission. Thus, Δ9-THC and heroin exert similar effects on mesolimbic dopamine transmission through a common μ1 opioid receptor mechanism located in the ventral mesencephalic tegmentum.

  • * Present address: Department of Neuroscience, University “La Sapienza,” Viale dell'Università 30, 00185 Roma, Italy.

View Full Text

Related Content